Henry Schein, Inc.
HS2.DE
Deutsche Börse74.06
EUR
+0.08
- -
Henry Schein, Inc.
HS2.DE
(Deutsche Börse)
Recent
price
74.06
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Henry Schein, Inc. is a global provider of healthcare products and services primarily serving office-based dental, medical, and veterinary practitioners. The company offers an extensive portfolio including dental products and equipment such as consumables, laboratory equipment, implants, anesthetics; medical products including medicines, vaccines, vitamins, surgical materials, diagnostic tests, and pharmaceuticals; as well as veterinary supplies. Additional offerings include management software, financial services, technology solutions, training programs, and equipment maintenance and repair services. Henry Schein operates through three primary segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The company supports over 1 million healthcare professionals with a product selection exceeding 300,000 SKUs and conducts business in 33 countries, with the U.S. accounting for about 69.5% of net sales. It is headquartered in Melville, New York, and was founded in 1932. In recent developments, Henry Schein completed the acquisition of Shield Healthcare, a homecare medical supplies company, to expand its footprint in the home-based care market by delivering products such as incontinence, urology, ostomy, enteral nutrition, advanced wound care, diabetes supplies, and continuous glucose monitoring devices directly to patients’ homes. The company also expanded its strategic partnership with private equity firm KKR, which includes provisions for KKR to increase ownership in Henry Schein and collaborate on strategic growth, operational excellence, and capital allocation. Henry Schein further extended its exclusive U.S. distribution rights for cutting-edge dental products through an expanded partnership with vVARDIS. The company reported 2024 sales of $12.7 billion and continues investing in share repurchases and operational improvements to drive shareholder value. Overall, Henry Schein is recognized as the world’s largest distributor of health care solutions for office-based practitioners, maintaining a comprehensive product and service offering across dental, medical, and veterinary sectors, and pursuing growth through strategic acquisitions, partnerships, and technological integration.